www.fdanews.com/articles/198449-diasorin-earns-ce-mark-for-testosterone-test
DiaSorin Earns CE Mark for Testosterone Test
August 10, 2020
DiaSorin has received a CE mark for its LIAISON Testosterone xt assay for detecting fertility disorders.
The in vitro diagnostic test is a chemiluminescence immunoassay (CLIA) that measures the amount of testosterone in a patient’s serum and plasma.
The company said it has launched the test in Europe, based on a CE mark certification.